Human antibody that targets carfentanil, fentanyl and related opioids reverses overdose effects in preclinical study

An antibody in single-chain fragment variable (scFv) format that binds to the powerful opioid carfentanil was shown to reverse signs of carfentanil overdose in preclinical tests conducted by scientists at Scripps Research. Carfentanil is a variant of the synthetic opioid fentanyl, and about 100 times as potent as its chemical cousin.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news